| Literature DB >> 30632016 |
Pontus Öhlund1, Hanna Lundén1, Anne-Lie Blomström2.
Abstract
The advancement in high-throughput sequencing technology and bioinformatics tools has spurred a new age of viral discovery. Arthropods is the largest group of animals and has shown to be a major reservoir of different viruses, including a group known as insect-specific viruses (ISVs). The majority of known ISVs have been isolated from mosquitoes and shown to belong to viral families associated with animal arbovirus pathogens, such as Flaviviridae, Togaviridae and Phenuiviridae. These insect-specific viruses have a strict tropism and are unable to replicate in vertebrate cells, these properties are interesting for many reasons. One is that these viruses could potentially be utilised as biocontrol agents using a similar strategy as for Wolbachia. Mosquitoes infected with the viral agent could have inferior vectorial capacity of arboviruses resulting in a decrease of circulating arboviruses of public health importance. Moreover, insect-specific viruses are thought to be ancestral to arboviruses and could be used to study the evolution of the switch from single-host to dual-host. In this review, we discuss new discoveries and hypothesis in the field of arboviruses and insect-specific viruses.Entities:
Keywords: Arbovirus; Evolution; Insect-specific virus; Vector competence
Mesh:
Year: 2019 PMID: 30632016 PMCID: PMC6458977 DOI: 10.1007/s11262-018-01629-9
Source DB: PubMed Journal: Virus Genes ISSN: 0920-8569 Impact factor: 2.332
Fig. 1Schematic overview of some of the mosquito antiviral mechanisms. a The mosquito ingests an arbovirus-infectious blood meal into the midgut. The virus enters and replicate in the midgut epithelial cells, after successful replication the virus escape into the haemolymph and spread systemically including to the salivary glands, where the virus enters and replicate before being transmitted via the saliva. b The JAK-STAT pathway is mainly activated when the transmembrane receptor Domeless (Dome) recognise extracellular unpaired ligands (Upd) leading to a conformational change that start autophosphorylation of Hop, which in turn phosphorylates Dome. This is leads to the phosphorylation and dimerization of STAT, resulting in a translocation of STAT dimers to the nucleus which activates the transcription of specific antiviral genes. c A primary viral infection can block a secondary infection of a similar virus via mechanisms hypothesised to involve competition for, or modification of cellular resources reducing receptor binding, viral entry, RNA replication and translation of the secondary virus. d Viral dsRNA, either as replication intermediates or as part of the viral genomes, are processed by the Dcr-2-R2D2 complex to generate siRNAs of approximately 21–23 bp of length. The siRNA are incorporated into the RNA-induced silencing complex (RISC) to recognize viral RNA for degradation. dsRNA can be sensed by the Dicer-2 DEcD/H-box helicase domain and via an unknown pathway activate expression and secretion of Vago, which can activate the JAK-STAT pathway via an unknown receptor in nearby cells
Summary of the papers discussed in the “Vector competence studies” subsection regarding the effect of different ISVs on vector competence
| Study | ISV | In vitro | In vivo | Control virus | Effect | Year | References |
|---|---|---|---|---|---|---|---|
| Kent et al. | CxFV | Yes | Yes | WNV | No effect on vector competence for WNV | 2010 | [ |
| Bolling et al. | CxFV | Yes | Yes | WNV | Early interference of infection, no effect on transmission | 2012 | [ |
| Hopson-Peter et al. | PCV | Yes | No | WNV, MVEV | 10–43-fold growth inhibition in C6/36 cells | 2013 | [ |
| Kenney et al. | NHUV | Yes | No | WNV, SLEV, JEV | 1.5 million-fold reduction for WNV, 80-fold reduction for JEV and 15,000-fold reduction for SLEV in C6/36 | 2014 | [ |
| Goenaga et al. | NHUV | Yes | Yes | WNV | 4000-fold reduction for WNV in vitro. No significant effect in co-infected | 2015 | [ |
| Kuwata et al. | CxFV | Yes | No | JEV, DENV | Pre-existing CxFV infection do not suppress growth of a superinfecting flavivirus but rather enhance virus release from the NIID-CTR cells | 2015 | [ |
| Nasar et al. | EILV | Yes | Yes | SINV, VEEV, EEEV, WEEV, CHIKV | In vitro results showed that EILV infection reduced superinfecting virus production by 10 to 10,000-fold and delayed replication kinetics at least 12–48 h regardless of virus or MOI. In vivo studies showed a delay of dissemination from the midgut by 3 days | 2015 | [ |
| Hall-Mendelin et al. | PCV | No | Yes | WNV | Significantly lower infection rate in PCV-infected | 2016 | [ |
| Talavera et al. | CxFV | No | Yes | RFV | No effect | 2018 | [ |
| Schultz et al. | CFAV, PCLV | Yes | No | ZIKV, DENV & LACV | 90% reduction of ZIKV & DENV growth. Complete inhibition of LACV at MOI 0.1 | 2018 | [ |